Envoy Medical
COCH
94 hedge funds and large institutions have $372M invested in Envoy Medical in 2022 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 14 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
43% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 14
3% more capital invested
Capital invested by funds: $361M → $372M (+$11.3M)
0.02% more ownership
Funds ownership: 87.16% → 87.18% (+0.02%)
0% more funds holding
Funds holding: 94 → 94 (0)
0% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 14
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
KIM
Karpus Investment Management
Pittsford,
New York
|
+$9.02M |
| 2 |
Jane Street
New York
|
+$5.21M |
| 3 |
CIM
Cowen Investment Management
New York
|
+$3.48M |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$2.98M |
| 5 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$2.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$34M |
| 2 |
BNP Paribas Financial Markets
Paris,
France
|
-$8.37M |
| 3 |
HCM
Highbridge Capital Management
New York
|
-$2.95M |
| 4 |
CF
Cantor Fitzgerald
New York
|
-$2.88M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$852K |
COCH Hedge Fund Activity: Q4 2022 in Review
94 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical (COCH) for Q4 2022, worth a combined $372M — up 3.1% from $361M a quarter earlier.
Fund positioning in COCH was balanced in Q4 2022: 14 funds opened new positions, 14 closed out, 20 added to existing stakes and 14 trimmed.
The largest buyer was Karpus Investment Management, adding an estimated $9.02M. The largest seller was Glazer Capital LLC, cutting an estimated $34M.
- 94 institutional investors held Envoy Medical (COCH) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $372M of Envoy Medical stock for Q4 2022, up 3.1% quarter-over-quarter.
- 14 funds opened new Envoy Medical positions in Q4 2022 and 14 closed out, a net change of 0 holders.
- The largest Envoy Medical buyer in Q4 2022 was Karpus Investment Management, an estimated $9.02M added.
- The largest Envoy Medical seller in Q4 2022 was Glazer Capital LLC, an estimated $34M sold.
Based on aggregated 13F filings for Q4 2022.